Salvatore Grisanti

TL;DR: The data demonstrate that autologous or allogeneic BMSCs strongly suppress T-lymphocyte proliferation, this phenomenon that is triggered by both cellular as well as nonspecific mitogenic stimuli has no immunologic restriction, and T-cell inhibition is not due to induction of apoptosis and is likely due to the production of soluble factors.

TL;DR: Amifostine selectively protects human CFU-GM progenitor cells from the cytotoxicities of active metabolites of cyclophosphamide without altering its cytot toxic effect on malignant cells, as demonstrated in patients with breast cancer, malignant lymphomas, and acute leukemia.

TL;DR: The coexistence of Langerhans' cell histiocytosis (LCH) and non-Hogkin's lymphoma (NHL) has only rarely been reported as mentioned in this paper and the close topographic association of the two processes in the same node and the frequency of this phenomenon point to a definite relation between them.

TL;DR: A retrospective analysis of the multicentre OnCovid Registry study, which recruited patients aged 18 years or older with laboratory-confirmed diagnosis of SARS-CoV-2, who had a history of solid or haematological malignancy that was either active or in remission, to describe outcomes due to COVID-19 during the omicron outbreak compared with the prevaccination period.

TL;DR: The findings suggest that a deranged proinflammatory reaction at COVID-19 diagnosis may predict for sequelae development, and the association between inflammatory status, recent chemotherapy and sequelae warrants further investigation.